Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue polypeptide antigen in bronchogenic carcinoma

P Zatloukal1, A Glagolicová, M Linhart

  • 11st Chest Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Neoplasma
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous Obstruction in Asymptomatic Patients Undergoing First Implantation or Revision of a Cardiac Pacemaker or Implantable Cardioverter-Defibrillator: A Retrospective Single Center Analysis.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2015
Same author

[The TULUNG clinical registry].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2012
Same author

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

[TARCEVA Clinical Registry].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2010
Same author

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

[Urogenital trauma associated with pelvic ring fractures].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2010

Serum tissue polypeptide antigen (TPA) levels show limited diagnostic value for bronchogenic carcinoma. However, elevated TPA may aid in staging advanced lung cancer cases.

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Tissue polypeptide antigen (TPA) is a tumor-associated marker.
  • Accurate diagnosis and staging of bronchogenic carcinoma are crucial for effective treatment.

Purpose of the Study:

  • To evaluate the diagnostic utility of serum TPA levels in bronchogenic carcinoma.
  • To assess the correlation of TPA levels with disease stage and histologic type.

Main Methods:

  • An immunoradiometric technique was used to measure serum TPA concentrations.
  • The study included 114 patients with bronchogenic carcinoma and 55 with noncancerous lung diseases.

Main Results:

  • TPA sensitivity for bronchogenic carcinoma was 67.5%, increasing with advanced stages.
  • No significant differences in TPA levels were found across histologic types.

Related Experiment Videos

  • Elevated TPA levels were observed in 21.8% of patients with nonmalignant lung diseases.

    • Conclusions:

    • Serum TPA has limited value as a standalone diagnostic marker for bronchogenic carcinoma.
    • TPA may serve as an auxiliary criterion for staging lung cancer.